Cleared Traditional

Synapse 3D Cardiac Tools (K200973) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200973 · Fujifilm Corporaton · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
136d
Days
Class 2
Risk

K200973 is an FDA 510(k) clearance for the Synapse 3D Cardiac Tools. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Corporaton (Tokyo, JP). The FDA issued a Cleared decision on August 27, 2020 after a review of 136 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Corporaton devices

Submission Details

510(k) Number K200973 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 2020
Decision Date August 27, 2020
Days to Decision 136 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d slower than avg
Panel avg: 107d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Fujifilm Medical Systems U.S.A, Inc.
Tommy San

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 787
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K200973.
AcroDTI Visualizer
K201948 · Acroviz, Inc. · Sep 2020
3Shape Implant Studio
K202256 · 3Shape Medical A/S · Sep 2020
Ambra ProViewer
K202335 · Dicom Grid Inc Dba Ambra Health · Sep 2020
AVIEW
K200714 · Coreline Soft Co., Ltd. · Aug 2020
EzDent-i/ E2/ Prora View/ Smart M Viewer
K202116 · Ewoosoft Co., Ltd. · Aug 2020
3D Auto LAA
K201352 · Philips Health Care · Aug 2020